[1] 陈耿谊, 高镇松, 张胜佳, 等. 定期监测心电图和心肌酶早期发现抗精神病药心脏副作用研究[J]. 河北医学, 2014, 20(9):1427-1430. [2] 兰庆榜, 黄海燕, 陶世武. 3种AAs对精神分裂症患者心电图的影响[J]. 临床精神医学杂志, 2011, 21(4):267-269. [3] 刘欣, 石少波, 杨波. NAt物引起QT间期延长的研究进展[J]. 临床误诊误治, 2016, 29(8):105-108. [4] Polymeropoulos MH. Common effect of antipsychotics on the biosynthesis and regulation of fatty acids and cholesterol supports a key role of lipid homeostasis in schizophrenia [J]. Schizophr Res, 2009, 108(1-3):134-142. [5] Leung JY, Barr AM, Procyshyn RM, et al. Cardiovascular side-effects of antipsychotic drugs:the role of the autonomic nervous system[J]. Pharmacol Ther, 2012, 135(2):113-122. [6] Lee S. Cellular mechanisms for trazodone-induced cardiotoxicity[J]. Hum Exp Toxicol, 2016, 35(5):501-510. [7] Nezafati MH, Vojdanparast M, Nezafati P, et al. Antidepressants and cardiovascular adverse events: A narrative review[J]. ARYA Atheroscler, 2015, 11(5):295-304. [8] Pollock BG, Laghrissi-Thode F, Wagner WR. Evaluation of platelet activation in depressed patients with ischemic heart disease after paroxetine or nortriptyline treatment[J]. J Clin Psychopharmacol, 2000, 20(2):137-140. [9] Polcwiartek C, Sneider B, Graff C, et al. The cardiac safety of aripiprazole treatment in patients at high risk for torsade: a systematic review with a meta-analytic approach[J]. Psychopharmacology(Berl), 2015, 232(18):3297-3308. [10] Nielsen J, Graff C, Kanters JK, et al. Assessing QT interval prolongation and its associated risks with antipsychotics[J]. CNS Drugs, 2011, 25(6):473-490. [11] Miceli JJ, Tensfeldt G, Shiovitz T, et al. Effects of oral ziprasidone and oral haloperidol on QTc interval in patients with schizophrenia or schizoaffective disorder [J]. Pharmacotherapy, 2010, 30(2):127-135. [12] Wooltorton E. Olanzapine(Zyprexa):increased incidence of cerebrovascular events in dementia trials[J]. CMAJ, 2004, 27, 170(9):1395. [13] Zivin K, Pfeiffer PN, Bohnert ASB, et al. Evaluation of the FDA warning against prescribing citalopram at doses exceeding 40 mg[J]. Am J Psychiatry, 2013, 170(6):642-650. [14] Castro VM, Clements CC, Murphy SN, et al. QT interval and antidepressant use: a cross sectional study of electronic health records[J]. BMJ, 2013, 346:288.
2017, Vol. 34 
